Atlas Trials

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

Clinical trial NCT00293904 · COMPLETED

Trial details

NCT number
NCT00293904
Sponsor
Cytos Biotechnology AG
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hypersensitivity
Start date
2006-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.